Filing Details
- Accession Number:
- 0001628280-24-045331
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-05 16:39:40
- Reporting Period:
- 2024-10-01
- Accepted Time:
- 2024-11-05 16:39:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1490829 | James Jones | 1600 West End Avenue, Suite 1300 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-10-01 | 62 | $1.27 | 36,507 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-02 | 62 | $1.29 | 36,569 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-03 | 62 | $1.28 | 36,631 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-04 | 62 | $1.28 | 36,693 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-07 | 62 | $1.29 | 36,755 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-08 | 62 | $1.30 | 36,817 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-09 | 62 | $1.31 | 36,879 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-10 | 62 | $1.32 | 36,941 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-11 | 62 | $1.39 | 37,003 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-14 | 62 | $1.37 | 37,065 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-15 | 62 | $1.30 | 37,127 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-16 | 62 | $1.25 | 37,189 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-17 | 62 | $1.30 | 37,251 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-18 | 62 | $1.28 | 37,313 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-21 | 62 | $1.25 | 37,375 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-22 | 62 | $1.25 | 37,437 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-23 | 62 | $1.26 | 37,499 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-24 | 62 | $1.24 | 37,561 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-25 | 62 | $1.23 | 37,623 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-28 | 62 | $1.25 | 37,685 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-29 | 62 | $1.24 | 37,747 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-30 | 62 | $1.32 | 37,809 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-31 | 62 | $1.20 | 37,871 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Footnotes
- The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.
Billionaire Hedge Funds
